Putnam Investments’s Achieve Life Sciences ACHV Stock Holding History

Putnam Investments’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-23	Closed	-$50K	–	1256
2016 Q2	$50K	Hold	23	–	–	﹤0.01%	1324
2016 Q1	$34K	Hold	23	–	–	﹤0.01%	1391
2015 Q4	$61K	Hold	23	–	–	﹤0.01%	1439
2015 Q3	$112K	Hold	23	–	–	﹤0.01%	1459
2015 Q2	$117K	Hold	23	–	–	﹤0.01%	1479
2015 Q1	$108K	Hold	23	–	–	﹤0.01%	1473
2014 Q4	$115K	Hold	23	–	–	﹤0.01%	1455
2014 Q3	$134K	Hold	23	–	–	﹤0.01%	1492
2014 Q2	$187K	Hold	23	–	–	﹤0.01%	1443
2014 Q1	$590K	Hold	23	–	–	﹤0.01%	1320
2013 Q4	$417K	Hold	23	–	–	﹤0.01%	1381
2013 Q3	$464K	Hold	23	–	–	﹤0.01%	1357
2013 Q2	$490K	Buy	+23	New	+$514K	﹤0.01%	1327

Other funds holding ACHV

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EGA

Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Putnam Investments's ACHV Position: Q3 2016 in Review

Putnam Investments sold out of Achieve Life Sciences (ACHV) in Q3 2016, closing a stake of 23 shares — an estimated $50K sold.

Putnam Investments first reported a position in ACHV in Q2 2013 and held it in 13 quarters. The position peaked at $590K in Q1 2014. 29 funds tracked by Wall St. Rank hold ACHV as of Q3 2016.

Putnam Investments reported no remaining Achieve Life Sciences position as of Q3 2016 after selling out during the quarter.
Putnam Investments sold 23 Achieve Life Sciences shares in Q3 2016, an estimated $50K.
Putnam Investments first reported a position in Achieve Life Sciences in Q2 2013 and held it in 13 quarters.
Putnam Investments's Achieve Life Sciences position peaked at $590K in Q1 2014.
29 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2016.

Based on Putnam Investments's 13F filing for Q3 2016, filed 14 Nov 2016.